Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Immunotherapy of lung cancer.

Owonikoko TK, Borghaei H.

J Thorac Dis. 2018 Feb;10(Suppl 3):S395-S396. doi: 10.21037/jtd.2018.01.142. No abstract available.

2.

The state of the art in non-small cell lung cancer immunotherapy.

Seetharamu N.

Semin Thorac Cardiovasc Surg. 2014 Spring;26(1):26-35. doi: 10.1053/j.semtcvs.2014.02.005. Epub 2014 Mar 26. Review.

PMID:
24952755
3.

Immunotherapy of lung cancer: an update.

Rüttinger D, Winter H, van den Engel NK, Hatz RA, Schlemmer M, Pohla H, Grützner S, Schendel DJ, Fox BA, Jauch KW.

Onkologie. 2006 Feb;29(1-2):33-8. Review.

PMID:
16514254
4.

Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer.

Kakimi K, Nakajima J, Wada H.

Lung Cancer. 2009 Jul;65(1):1-8. doi: 10.1016/j.lungcan.2008.10.018. Epub 2008 Dec 4. Review.

PMID:
19062127
5.

Immune Therapy.

Lievense L, Aerts J, Hegmans J.

Adv Exp Med Biol. 2016;893:59-90. doi: 10.1007/978-3-319-24223-1_4. Review.

PMID:
26667339
6.

What lies within: novel strategies in immunotherapy for non-small cell lung cancer.

Forde PM, Reiss KA, Zeidan AM, Brahmer JR.

Oncologist. 2013;18(11):1203-13. doi: 10.1634/theoncologist.2013-0171. Epub 2013 Oct 8. Review.

7.

Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?

Rolfo C, Sortino G, Smits E, Passiglia F, Bronte G, Castiglia M, Russo A, Santos ES, Janssens A, Pauwels P, Raez L.

Expert Rev Anticancer Ther. 2014 Oct;14(10):1173-87. doi: 10.1586/14737140.2014.952287. Epub 2014 Aug 22. Review.

PMID:
25148289
8.

Immunotherapy for lung cancers.

Ho MY, Tang SJ, Sun KH, Yang W.

J Biomed Biotechnol. 2011;2011:250860. doi: 10.1155/2011/250860. Epub 2011 Jan 24.

9.

High hydrostatic pressure affects antigenic pool in tumor cells: Implication for dendritic cell-based cancer immunotherapy.

Urbanova L, Hradilova N, Moserova I, Vosahlikova S, Sadilkova L, Hensler M, Spisek R, Adkins I.

Immunol Lett. 2017 Jul;187:27-34. doi: 10.1016/j.imlet.2017.05.005. Epub 2017 May 8.

PMID:
28495513
10.

Immunotherapy for non-small cell lung cancer: are we on the cusp of a new era?

Waqar SN, Morgensztern D.

Expert Rev Clin Immunol. 2015;11(8):871-3. doi: 10.1586/1744666X.2015.1054374. Epub 2015 Jun 7. Review.

PMID:
26051156
11.

HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody.

Wang W, Nishioka Y, Ozaki S, Jalili A, Abe S, Kakiuchi S, Kishuku M, Minakuchi K, Matsumoto T, Sone S.

Cancer Immunol Immunother. 2009 Jun;58(6):967-76. doi: 10.1007/s00262-008-0612-4. Epub 2008 Nov 1.

PMID:
18979097
12.

[Non-Small Cell Lung Cancer - from Immunobiology to Immunotherapy].

Bílek O, Bohovicová L, Demlová R, Poprach A, Lakomý R, Zdražilová-Dubská L.

Klin Onkol. Fall 2016;29 Suppl 4(Suppl 4):78-87. Review. Czech.

PMID:
27846725
13.

[Present Experience and Perspectives of Immunotherapy of Lung Cancer].

Havel L.

Klin Onkol. 2015;28 Suppl 4:4S73-6. Review. Czech.

PMID:
26647893
14.

Trends and advances in tumor immunology and lung cancer immunotherapy.

Aldarouish M, Wang C.

J Exp Clin Cancer Res. 2016 Sep 29;35(1):157. Review.

15.

Upcoming innovations in lung cancer immunotherapy: focus on immune checkpoint inhibitors.

Aspeslagh S, Marabelle A, Soria JC, Armand JP.

Chin Clin Oncol. 2015 Dec;4(4):48. doi: 10.3978/j.issn.2304-3865.2015.12.06. Review.

16.

Adjuvant immunotherapy for non-small cell lung cancer.

Tucker ZC, Laguna BA, Moon E, Singhal S.

Cancer Treat Rev. 2012 Oct;38(6):650-61. doi: 10.1016/j.ctrv.2011.11.008. Epub 2012 Jan 9. Review.

PMID:
22226940
17.

Immunotherapy for lung cancer.

Hirschowitz EA, Yannelli JR.

Proc Am Thorac Soc. 2009 Apr 15;6(2):224-32. doi: 10.1513/pats.200806-048LC. Review.

PMID:
19349492
18.

[Thorax/Lung and Mediastinum, Pleura: Cancer Immunotherapy for Lung Cancer - The Beginning of a New Era in the Treatment of Lung Cancer].

Takenoyama M.

Gan To Kagaku Ryoho. 2017 Aug;44(8):644-645. Japanese. No abstract available.

PMID:
28860433
19.

Advances in immunotherapy for non-small cell lung cancer.

Reckamp KL.

Clin Adv Hematol Oncol. 2015 Dec;13(12):847-53. Review.

PMID:
27058851
20.

Immunotherapy for lung cancer: for whom the bell tolls?

Madureira P, de Mello RA, de Vasconcelos A, Zhang Y.

Tumour Biol. 2015 Mar;36(3):1411-22. doi: 10.1007/s13277-015-3285-6. Epub 2015 Mar 4. Review.

PMID:
25736929

Supplemental Content

Support Center